Healthcare
Live Price
Offline$12.75
-50.96% today
1Y Change
—
Window
No data
Historical coverage is still loading
We are still backfilling 1Y daily history for this symbol. Some charts may stay empty until more data arrives.
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Carmat S.A. (CKMTF) is a Healthcare stock with a market cap of $85.19M. The stock last traded around $12.75. Baseline metrics include revenue growth of +652.7%, EPS growth of +8.0%, a dividend yield of 0.0%. What stands out right now is revenue +652.7%, EPS +8.0%, free cash flow -4.2% with operating margin -702.9% and ROIC -191.8%. Valuation is more restrained than many high-expectation growth names at price/sales 0.9. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines CKMTF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
CKMTF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
CKMTF Max Drawdown
—
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for CKMTF and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$14.0K
+55.6% YoY
FY Net Income
-$42.6M
-15.4% YoY
Free Cash Flow
-$40.9M
+9.8% YoY
Revenue Growth
+652.7%
EPS Growth
+8.0%
Gross Margin
0.0%
Net Margin
-734.3%
Income statement
EUR
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 3M | 372K | 2M | 9K | 14K |
| Gross Profit | -48M | -28M | -33M | -20M | -28M |
| Operating Income | -53M | -52M | -60M | -36M | -42M |
| EBITDA | -46M | -50M | -52M | -28M | -42M |
| Net Income | -54M | -54M | -62M | -37M | -43M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
EUR
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Cash & Equivalents | 8M | 51M | 39M | 36M | 56M |
| Total Assets | 53M | 85M | 69M | 60M | 65M |
| Total Liabilities | 97M | 83M | 83M | 67M | 40M |
| Shareholder Equity | -44M | 2M | -14M | -7M | 24M |
| Total Debt | 58M | 55M | 52M | 39M | 16M |
| Net Debt | 50M | 4M | 13M | 3M | -39M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
40M
+6.5% YoY
Capital Expenditures
649K
+72.1% YoY
Free Cash Flow
41M
+9.8% YoY
Key ratios
Gross Margin
0.0%
Operating Margin
-702.9%
Net Margin
-734.3%
ROE
106.8%
Debt / Equity
-1.13x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.